-
1دورية أكاديمية
المؤلفون: Bergler-Klein, Jutta, Gotcheva, Nina, Kalējs, Oskars, Kalarus, Zbigniew, Kovačić, Dragan, Peršić, Viktor, Shlyakhto, Evgeny, Uuetoa, Tiina, Huisman, Menno V., Lip, Gregory Y. H., Vinereanu, Dragos
المصدر: Bergler-Klein , J , Gotcheva , N , Kalējs , O , Kalarus , Z , Kovačić , D , Peršić , V , Shlyakhto , E , Uuetoa , T , Huisman , M V , Lip , G Y H , Vinereanu , D & GLORIA-AF Investigators 2024 , ' Antithrombotic Usage, Including Three-Year Outcomes With Dabigatran and Vitamin K Antagonists for Atrial Fibrillation, in Eastern Europe: A Descriptive Analysis From Phase 3 of the GLORIA-AF Registry ' , American Journal of Therapeutics , vol. 31 , no. 1 , pp. e1-e12 . https://doi.org/10.1097/MJT.0000000000001655Test
مصطلحات موضوعية: Anticoagulants/adverse effects, Atrial Fibrillation/complications, Dabigatran/adverse effects, Europe, Eastern/epidemiology, Fibrinolytic Agents/adverse effects, Hemorrhage/chemically induced, Humans, Myocardial Infarction/epidemiology, Stroke/epidemiology, Vitamin K, GLORIA-AF, vitamin K antagonist, atrial fibrillation, dabigatran, stroke prevention
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1097/MJT.0000000000001655Test
https://vbn.aau.dk/da/publications/ad05e788-b638-45f7-9bf4-41d5cf808409Test
https://vbn.aau.dk/ws/files/667524449/Bergler-Klein_et_al._2024_._Antithrombotic_Usage_Including_Three-Year_Outcomes_With_Dabigatran_and_Vitamin_K_Antagonists_for_Atrial_Fibrillation_in_Eastern_Europe_A_Descriptive_Analysis_From_Phase_3_of_the_GLORIA-AF_Regi.pdfTest
http://www.scopus.com/inward/record.url?scp=85183071218&partnerID=8YFLogxKTest -
2دورية أكاديمية
المؤلفون: Halvorsen, Sigrun, Johnsen, Søren P, Madsen, Morten, Linder, Marie, Sulo, Gerhard, Ghanima, Waleed, Gislason, Gunnar, Hohnloser, Stefan H, Jenkins, Aaron, Al-Khalili, Faris, Tell, Grethe S, Ehrenstein, Vera
المصدر: Halvorsen , S , Johnsen , S P , Madsen , M , Linder , M , Sulo , G , Ghanima , W , Gislason , G , Hohnloser , S H , Jenkins , A , Al-Khalili , F , Tell , G S & Ehrenstein , V 2022 , ' Effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in atrial fibrillation : a Scandinavian population-based cohort study ' , European heart journal - Quality of care & clinical outcomes , vol. 8 , no. 5 , pp. 577-587 . https://doi.org/10.1093/ehjqcco/qcab048Test
مصطلحات موضوعية: APIXABAN, Anticoagulants, Atrial fibrillation, Bleeding, Cohort study, DABIGATRAN, EFFICACY, MANAGEMENT, PATIENT REGISTRY, QUALITY, RIVAROXABAN, Stroke, VALIDATION, WORLD, Humans, Dabigatran/adverse effects, Male, Embolism/epidemiology, Rivaroxaban/adverse effects, Female, Anticoagulants/adverse effects, Hemorrhage/chemically induced, Warfarin/adverse effects, Stroke/epidemiology, Aged, Atrial Fibrillation/complications, Cohort Studies
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1093/ehjqcco/qcab048Test
https://pure.au.dk/portal/en/publications/21e4c304-50fd-47ca-a006-38da6f40efe5Test
https://pure.au.dk/ws/files/331566481/qcab048.pdfTest -
3دورية أكاديمية
المؤلفون: Chandrasegaram, Agitha, Peters, Christian Daugaard
المصدر: Chandrasegaram , A & Peters , C D 2022 , ' The use of non-vitamin K oral anticoagulants in dialysis patients-A systematic review ' , Seminars in Dialysis , vol. 35 , no. 6 , pp. 463-480 . https://doi.org/10.1111/sdi.13098Test
مصطلحات موضوعية: Administration, Oral, Anticoagulants/therapeutic use, Atrial Fibrillation/drug therapy, Dabigatran/adverse effects, Hemorrhage/chemically induced, Humans, Renal Dialysis/adverse effects, Rivaroxaban/adverse effects, Stroke/drug therapy, Vitamin K/therapeutic use
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1111/sdi.13098Test
https://pure.au.dk/portal/en/publications/5196ef53-82c2-468f-952b-1f8dd31f8e7eTest
https://pure.au.dk/ws/files/339866084/Seminars_in_Dialysis_-_2022_-_Chandrasegaram.pdfTest -
4دورية أكاديمية
المؤلفون: Beier, Lea, Lu, Shihai, França, Lionel Riou, Marler, Sabrina, Lip, Gregory Y. H., Huisman, Menno V., Teutsch, Christine, Halperin, Jonathan L., Zint, Kristina, Diener, Hans-Christoph, Baker, Laurie, Ma, Chang-Sheng, Paquette, Miney, Bartels, Dorothee B., Dubner, Sergio J., Lyrer, Philippe, Senges, Jochen, Rothman, Kenneth J.
المصدر: Beier , L , Lu , S , França , L R , Marler , S , Lip , G Y H , Huisman , M V , Teutsch , C , Halperin , J L , Zint , K , Diener , H-C , Baker , L , Ma , C-S , Paquette , M , Bartels , D B , Dubner , S J , Lyrer , P , Senges , J & Rothman , K J 2022 , ' Evolution of antithrombotic therapy for patients with atrial fibrillation : The prospective global GLORIA-AF registry program ' ....
مصطلحات موضوعية: Administration, Oral, Anticoagulants/adverse effects, Atrial Fibrillation/chemically induced, Dabigatran/adverse effects, Fibrinolytic Agents/adverse effects, Humans, Registries, Stroke/chemically induced, Vitamin K
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1371/journal.pone.0274237Test
https://vbn.aau.dk/da/publications/b741119e-881e-4fe6-9644-33b05ffb399aTest
https://vbn.aau.dk/ws/files/490644140/Beier_et_al._2022_._Evolution_of_antithrombotic_therapy_for_patients_with_atrial_fibrillation_The_prospective_global_GLORIA_AF_registry_program.pdfTest
http://www.scopus.com/inward/record.url?scp=85139377485&partnerID=8YFLogxKTest -
5دورية أكاديمية
المؤلفون: Lip, Gregory Y. H., Keshishian, Allison, Kang, Amiee, Luo, Xuemei, Atreja, Nipun, Zhang, Yan, Schuler, Patricia, Jiang, Jenny, Yuce, Huseyin, Deitelzweig, Steven
المصدر: Lip , G Y H , Keshishian , A , Kang , A , Luo , X , Atreja , N , Zhang , Y , Schuler , P , Jiang , J , Yuce , H & Deitelzweig , S 2022 , ' Effectiveness and safety of oral anticoagulants in non-valvular atrial fibrillation patients with prior bleeding events : a retrospective analysis of administrative claims databases ' , Journal of Thrombosis and Thrombolysis , vol. 54 , no. 1 , pp. 33-46 . https://doi.org/10.1007/s11239-022-02660-2Test
مصطلحات موضوعية: Major bleed, Non-vitamin K anticoagulant, Nonvalvular atrial fibrillation, Warfarin, Administration, Oral, Humans, Dabigatran/adverse effects, Male, Anticoagulants/adverse effects, Embolism/epidemiology, Hemorrhage/chemically induced, Rivaroxaban/adverse effects, Warfarin/adverse effects, Female, Stroke/epidemiology, Aged, Retrospective Studies, Atrial Fibrillation/complications
وصف الملف: application/pdf
الإتاحة: https://doi.org/10.1007/s11239-022-02660-2Test
https://vbn.aau.dk/da/publications/4cd3c9ba-50ad-4b5e-aa3d-0852d3b39c1fTest
https://vbn.aau.dk/ws/files/482463633/s11239_022_02660_2.pdfTest
http://www.scopus.com/inward/record.url?scp=85130246967&partnerID=8YFLogxKTest -
6دورية أكاديمية
المساهمون: Jiwon Kim, Hee Jeong Jang, Dawid Schellingerhout, Su-Kyoung Lee, Ha Kim, Young Dae Kim, Kyung-Yul Lee, Hye-Yeon Choi, Han-Jin Cho, Seong-Soo Jang, Sangmin Jeon, Ick Chan Kwon, Kwangmeyung Kim, Wi-Sun Ryu, Matthias Nahrendorf, Seungbum Choi, Dong-Eog Kim, Kim, Young Dae
مصطلحات موضوعية: Aged, 80 and over, Animals, Antithrombins / adverse effects, Antithrombins / pharmacology, Arachidonic Acid / blood, Aspirin / pharmacology, Carotid Artery Thrombosis / chemically induced, Carotid Artery Thrombosis / diagnostic imaging, Carotid Artery Thrombosis / prevention & control, Cerebral Infarction / diagnostic imaging, Cerebral Infarction / etiology, Cerebral Infarction / physiopathology, Cerebral Infarction / prevention & control, Chlorides / toxicity, Computed Tomography Angiography, Dabigatran / adverse effects, Dabigatran / pharmacology, Deprescriptions, Factor Xa Inhibitors / adverse effects, Female, Ferric Compounds / toxicity, Humans, Ischemic Stroke / diagnostic imaging, Ischemic Stroke / etiology, Ischemic Stroke / physiopathology, Ischemic Stroke / prevention & control, Magnetic Resonance Angiography, Male, Mean Platelet Volume
العلاقة: ANNALS OF NEUROLOGY; J00166; OAK-2021-05898; https://ir.ymlib.yonsei.ac.kr/handle/22282913/185385Test; T202103929; ANNALS OF NEUROLOGY, Vol.89(3) : 444-458, 2021-03
الإتاحة: https://doi.org/10.1002/ana.25964Test
https://ir.ymlib.yonsei.ac.kr/handle/22282913/185385Test -
7دورية أكاديمية
المؤلفون: Rodríguez-Bernal, Clara L, Santa-Ana-Téllez, Yared, García-Sempere, Aníbal, Hurtado, Isabel, Peiró, Salvador, Sanfélix-Gimeno, Gabriel
المساهمون: Afd Pharmacoepi & Clinical Pharmacology, Pharmacoepidemiology and Clinical Pharmacology
مصطلحات موضوعية: Acenocoumarol/adverse effects, Administration, Oral, Anticoagulants/adverse effects, Atrial Fibrillation/complications, Brain Ischemia/drug therapy, Cohort Studies, Dabigatran/adverse effects, Humans, India, Netherlands, Retrospective Studies, Rivaroxaban/adverse effects, Spain/epidemiology, Stroke/drug therapy
وصف الملف: application/pdf
-
8
المؤلفون: Wallis C.Y. Lau, Carmen Olga Torre, Kenneth K.C. Man, Henry Morgan Stewart, Sarah Seager, Mui Van Zandt, Christian Reich, Jing Li, Jack Brewster, Gregory Y.H. Lip, Aroon D. Hingorani, Li Wei, Ian C.K. Wong
المصدر: Lau, W C Y, Torre, C O, Man, K K C, Stewart, H M, Seager, S, Van Zandt, M, Reich, C, Li, J, Brewster, J, Lip, G Y H, Hingorani, A D, Wei, L & Wong, I C K 2022, ' Comparative Effectiveness and Safety Between Apixaban, Dabigatran, Edoxaban, and Rivaroxaban Among Patients With Atrial Fibrillation : A Multinational Population-Based Cohort Study ', Annals of Internal Medicine, vol. 175, no. 11, pp. 1515-1524 . https://doi.org/10.7326/M22-0511Test
مصطلحات موضوعية: Clinical Trials as Topic, Atrial Fibrillation/drug therapy, Embolism/epidemiology, Renal Insufficiency, Chronic/complications, Embolism, Anticoagulants, Administration, Oral, General Medicine, United States, Dabigatran, Cohort Studies, Rivaroxaban, Atrial Fibrillation, Internal Medicine, Humans, Renal Insufficiency, Chronic, Anticoagulants/adverse effects, Dabigatran/adverse effects, Rivaroxaban/adverse effects, Ischemic Stroke
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d793a0a23cf5b2d6eef4a02d1bf54c7eTest
https://vbn.aau.dk/da/publications/358dedc4-936d-4b8f-8ef3-97b512fadd84Test -
9
المؤلفون: Agitha Chandrasegaram, Christian Daugaard Peters
المصدر: Chandrasegaram, A & Peters, C D 2022, ' The use of non-vitamin K oral anticoagulants in dialysis patients-A systematic review ', Seminars in Dialysis, vol. 35, no. 6, pp. 463-480 . https://doi.org/10.1111/sdi.13098Test
مصطلحات موضوعية: Vitamin K, Atrial Fibrillation/drug therapy, Anticoagulants, Administration, Oral, Hemorrhage, Dabigatran, Stroke, Renal Dialysis/adverse effects, Rivaroxaban, Anticoagulants/therapeutic use, Renal Dialysis, Nephrology, Hemorrhage/chemically induced, Atrial Fibrillation, Vitamin K/therapeutic use, Humans, Dabigatran/adverse effects, Rivaroxaban/adverse effects, Stroke/drug therapy
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d017f8bf3c6dcc59afc28c1eb4519719Test
https://pure.au.dk/portal/da/publications/the-use-of-nonvitamin-k-oral-anticoagulants-in-dialysis-patientsa-systematic-reviewTest(5196ef53-82c2-468f-952b-1f8dd31f8e7e).html -
10دورية أكاديمية
المصدر: Tidsskrift for Den Norske Laegeforening. 138(12):1127
النص الكامل